Bora CDMO Bora CDMO

X

Find Aminaftone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

03JLX11PE9
Also known as: Aminaftone, Aminaphthone, 14748-94-8, Aminaphtone, (1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate, 03jlx11pe9
Molecular Formula
C18H15NO4
Molecular Weight
309.3  g/mol
InChI Key
YLMPBJUYFTWHKJ-UHFFFAOYSA-N
FDA UNII
03JLX11PE9

Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein Obstruction.
1 2D Structure

03JLX11PE9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate
2.1.2 InChI
InChI=1S/C18H15NO4/c1-10-15(20)13-4-2-3-5-14(13)16(21)17(10)23-18(22)11-6-8-12(19)9-7-11/h2-9,20-21H,19H2,1H3
2.1.3 InChI Key
YLMPBJUYFTWHKJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C2=CC=CC=C2C(=C1OC(=O)C3=CC=C(C=C3)N)O)O
2.2 Other Identifiers
2.2.1 UNII
03JLX11PE9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aminaftone

2. Aminaphthone

3. Capilarema

4. Capillarema

2.3.2 Depositor-Supplied Synonyms

1. Aminaftone

2. Aminaphthone

3. 14748-94-8

4. Aminaphtone

5. (1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate

6. 03jlx11pe9

7. Capilarema

8. Unii-03jlx11pe9

9. Capillarema

10. Menatriol

11. Capillarema (tn)

12. Einecs 238-809-8

13. Aminonaphthone

14. Aminaphthone [mart.]

15. Aminaphtone [who-dd]

16. Schembl12157532

17. Dtxsid00163725

18. Chebi:135317

19. Zinc5419379

20. Cs-6667

21. Db13039

22. Hy-19890

23. D07566

24. 3-methyl-1,2,4-naphthalenetriol-2-(4-aminobenzoate)

25. Q17620495

26. 1,2,4-naphthalenetriol, 3-methyl-, 2-(4-aminobenzoate)

27. 1,2,4-naphthalenetriol, 3-methyl-, 2-(p-aminobenzoate)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 309.3 g/mol
Molecular Formula C18H15NO4
XLogP33.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass309.10010796 g/mol
Monoisotopic Mass309.10010796 g/mol
Topological Polar Surface Area92.8 Ų
Heavy Atom Count23
Formal Charge0
Complexity421
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Hemostatics

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY